ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,324.44
-0.01%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) News

Heron Therapeautics (HRTX)

Heron Therapeautics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HRTX
DateTimeSourceHeadlineSymbolCompany
07/06/202414:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
31/05/202416:08Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
29/05/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
29/05/202413:05PR Newswire (US)Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
07/05/202413:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HRTXHeron Therapeautics Inc
07/05/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
07/05/202413:00PR Newswire (US)Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
24/04/202413:00PR Newswire (US)Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NASDAQ:HRTXHeron Therapeautics Inc
11/04/202421:05PR Newswire (US)Heron Therapeutics to Host Investor Day on May 15, 2024 in New York CityNASDAQ:HRTXHeron Therapeautics Inc
28/03/202420:05PR Newswire (US)Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:HRTXHeron Therapeautics Inc
13/03/202420:25AllPennyStocks.comBiotech Finds Mid-Week Success Following Q4 Earnings ReleaseNASDAQ:HRTXHeron Therapeautics Inc
12/03/202420:05PR Newswire (US)Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
12/03/202411:22IH Market NewsGlobal Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market TradingNASDAQ:HRTXHeron Therapeautics Inc
28/02/202413:00PR Newswire (US)Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024NASDAQ:HRTXHeron Therapeautics Inc
14/02/202421:37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
14/02/202421:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
14/02/202413:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
24/01/202414:25AllPennyStocks.comPremarket Heats Up For Biotech Before Opening BellNASDAQ:HRTXHeron Therapeautics Inc
24/01/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
24/01/202401:00PR Newswire (US)Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue ProceduresNASDAQ:HRTXHeron Therapeautics Inc
20/01/202402:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
20/01/202402:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
20/01/202402:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
20/01/202402:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
20/01/202402:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
20/01/202402:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
20/01/202402:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
20/01/202402:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
20/01/202402:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
20/01/202402:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
 Showing the most relevant articles for your search:NASDAQ:HRTX

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
ALTN
Altyngold
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved